Immunisation Coalition: HPV Update webinar recording
Các Immunisation Coalition HPV Update webinar was held on 13 March 2024, presented by Angela Newbound and moderated by Andrew Minton.
A recording of the webinar is now available on the Immunisation Coalition event page.
The Vaccine Coverage: MVEC’s new podcast is out!
MVEC has released the first two episodes of our new podcast, ‘The Vaccine Coverage’.
This series features conversations with special guests on a range of topics relating to vaccination in Australia.
The first two episodes cover vaccine myths, and how our body's respond when we receive a vaccine.
Listen on our website or search ‘The Vaccine Coverage’ in your favourite podcast app.
Updated immunisation reference page: Pneumococcal
Pneumococcal disease is a leading cause of serious illness in Australian children under 2 years and older Australians, and is responsible for over a million deaths worldwide every year.
Pneumococcal disease is caused by infection with the bacteria Phế cầu khuẩn. Symptoms vary depending on the site of infection; they may include fever, headache, earache and cough. Infection may result in meningitis (inflammation of the tissue surrounding the brain and spinal cord), pneumonia, septicaemia (blood infection) and osteomyelitis (bone infection), for example.
We have recently updated our pneumococcal reference page. The updated page includes more details on pneumococcal transmission and epidemiology, as well as detailed guidance on vaccine recommendations by age and risk category.
New publication: Analyzing an immunization resource website
Researchers from SAEFVIC (Surveillance of Adverse Events Following Vaccination In the Community) recently published an article in ‘Vaccine’, analysing user browsing trends on the MVEC website.
Over a four-year period from 2019 to 2022, there was specific interest in vaccine-related topics corresponding with key vaccine topics like COVID-19 vaccine administration techniques and adverse events following immunisation.
Vaccine: Analyzing an immunization resource website: User browsing trends
NCIRS: Webinar – Shingrix
Các Trung tâm Nghiên cứu và Giám sát Tiêm chủng Quốc gia (NCIRS) is hosting a webinar on Australia’s new National Immunisation Program (NIP) shingles (zoster) vaccine, Shingrix, to be held on Tuesday 7 November 2023 from 12:00 pm to 1:30 pm (AEDT).
Leading experts will present on:
- the disease burden of shingles in Australia
- details about Shingrix
- the new Australian Shingrix vaccination program
- the US experience of implementing a national Shingrix program.
ABC: Permanent funding for South Australian specialist immunisation service
SA Health will permanently fund the Women’s and Children’s Hospital’s specialist immunisation service, set up in 2021.
The unit supports patients with past trauma, neurodiverse conditions and needle phobia, offering sedation for vaccination and for minor medical procedures such as blood tests, dental check-ups and X-rays.
ABC: Needle phobia can impede jabs – but a hospital service is boosting vaccines and injections
NCIRS: Multiple vaccinations for children resource
Các Trung tâm Nghiên cứu và Giám sát Tiêm chủng Quốc gia (NCIRS) has recently developed a new resource to support conversations about administering multiple vaccinations at the same time in children.
NCIRS: Multiple vaccinations for children resource
The Lancet: Surge of invasive group A strep in Australia
The Lancet recently published a study, analysing data from the Paediatric Active Enhanced Disease Surveillance (PAEDS) Networks, which shows Australia experienced an intense and unseasonal surge of invasive group A streptococcal disease in 2022.
The national research project involved researchers from Murdoch Children’s Research Institute, including MVEC Director Prof Nigel Crawford.
Read the study in full: Increase in invasive group A streptococcal disease among Australian children coinciding with northern hemisphere surges
Bộ Y tế Victoria: Quản lý lỗi vắc xin
Bộ Y tế Victoria gần đây đã giới thiệu một tài nguyên tiêm chủng mới về quản lý lỗi vắc xin.
Tài nguyên bao gồm thông tin dễ hiểu về cách ngăn ngừa sai sót vắc-xin và các sai sót vắc-xin phổ biến nhất, cũng như hướng dẫn báo cáo sai sót vắc-xin cho SAEFVIC (Giám sát các Sự kiện Bất lợi Sau khi Tiêm chủng Trong Cộng đồng).
Sở Y tế: Quản lý sai sót vắc xin
Trang tham khảo cập nhật: Phát triển và đăng ký vắc xin
Vắc xin, giống như bất kỳ loại thuốc nào đang được phát triển, phải trải qua các quy trình thử nghiệm nghiêm ngặt và đánh giá khoa học để chứng minh không chỉ tác dụng của chúng đối với căn bệnh mục tiêu mà còn để xác định độ an toàn của chúng trước khi được cấp phép và đăng ký sử dụng trong các chương trình tiêm chủng.
Trang đăng ký và phát triển vắc-xin mới được cập nhật của chúng tôi bao gồm thông tin về các thử nghiệm lâm sàng vắc-xin, giám sát sau cấp phép, đăng ký và phê duyệt tạm thời, cũng như đánh giá kinh tế y tế của vắc-xin.
Cập nhật MVEC: Phát triển và đăng ký vắc xin